Mineralys Therapeutics, Inc. (MLYS)

Mineralys Therapeutics Statistics

Total Valuation

MLYS has a market cap or net worth of $1.89 billion. The enterprise value is $1.23 billion.

Market Cap	1.89B
Enterprise Value	1.23B

Important Dates

The last earnings date was Thursday, March 12, 2026, after market close.

Earnings Date	Mar 12, 2026
Ex-Dividend Date	n/a

Share Statistics

MLYS has 82.40 million shares outstanding. The number of shares has increased by 39.38% in one year.

Current Share Class	82.40M
Shares Outstanding	82.40M
Shares Change (YoY)	+39.38%
Shares Change (QoQ)	+14.10%
Owned by Insiders (%)	0.93%
Owned by Institutions (%)	85.88%
Float	60.54M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.88
P/TBV Ratio	2.92
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 43.76

Current Ratio	43.76
Quick Ratio	43.45
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -36.91% and return on invested capital (ROIC) is -25.45%.

Return on Equity (ROE)	-36.91%
Return on Assets (ROA)	-24.58%
Return on Invested Capital (ROIC)	-25.45%
Return on Capital Employed (ROCE)	-26.38%
Weighted Average Cost of Capital (WACC)	7.37%
Revenue Per Employee	n/a
Profits Per Employee	-$2.03M
Employee Count	76
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +35.63% in the last 52 weeks. The beta is 0.57, so MLYS's price volatility has been lower than the market average.

Beta (5Y)	0.57
52-Week Price Change	+35.63%
50-Day Moving Average	29.15
200-Day Moving Average	29.24
Relative Strength Index (RSI)	28.90
Average Volume (20 Days)	1,354,105

Short Selling Information

The latest short interest is 9.61 million, so 11.66% of the outstanding shares have been sold short.

Short Interest	9.61M
Short Previous Month	9.98M
Short % of Shares Out	11.66%
Short % of Float	15.87%
Short Ratio (days to cover)	9.16

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-170.60M
Pretax Income	-154.65M
Net Income	-154.65M
EBITDA	-170.55M
EBIT	-170.60M
Earnings Per Share (EPS)	-$2.29

Balance Sheet

The company has $656.64 million in cash and n/a in debt, with a net cash position of $656.64 million or $7.97 per share.

Cash & Cash Equivalents	656.64M
Total Debt	n/a
Net Cash	656.64M
Net Cash Per Share	$7.97
Equity (Book Value)	646.69M
Book Value Per Share	7.93
Working Capital	646.27M

Cash Flow

In the last 12 months, operating cash flow was -$142.42 million and capital expenditures -$15,000, giving a free cash flow of -$142.43 million.

Operating Cash Flow	-142.42M
Capital Expenditures	-15,000
Depreciation & Amortization	59,000
Net Borrowing	n/a
Free Cash Flow	-142.43M
FCF Per Share	-$1.73

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

MLYS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-39.38%
Shareholder Yield	-39.38%
Earnings Yield	-8.20%
FCF Yield	-7.55%

Analyst Forecast

The average price target for MLYS is $48.67, which is 112.72% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$48.67
Price Target Difference	112.72%
Analyst Consensus	Strong Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2